|
Market Cap | 19.51M | EPS (ttm) | 3.93 |
P/E | 0.75 | EPS this Y | 175.73% |
Forward P/E | - | EPS next Y | -257.18% |
PEG | - | EPS past 5Y | 24.44% |
P/S | 0.29 | EPS next 5Y | -0.10% |
P/B | 0.38 | EPS Q/Q | 40.88% |
Dividend | - | Sales Q/Q | -100.00% |
Insider Own | 7.66% | Inst Own | 43.38% |
Insider Trans | 0.00% | Inst Trans | 7.60% |
Short Float | 0.37% | Earnings | May 09/a |
Analyst Recom | 1.67 | Target Price | 22.67 |
Avg Volume | 20.22K | 52W Range | 2.99 - 6.91 |
|
|
|
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Anson Funds Management LP | 10% Owner | Sep 22 '23 | Buy | 6.85 | 48,060 | 329,331 | 864,188 | Sep 25 07:43 PM | Funicular Funds, LP | 10% Owner | Sep 22 '23 | Buy | 6.85 | 32,040 | 219,554 | 460,840 | Sep 25 07:41 PM | Anson Funds Management LP | 10% Owner | Sep 21 '23 | Buy | 6.46 | 33,600 | 217,110 | 816,128 | Sep 22 09:21 PM | Funicular Funds, LP | 10% Owner | Sep 21 '23 | Buy | 6.46 | 22,400 | 144,740 | 428,800 | Sep 22 09:19 PM | Anson Funds Management LP | 10% Owner | Sep 20 '23 | Buy | 6.01 | 120,000 | 721,116 | 782,528 | Sep 22 09:21 PM |
|
|
|
|
Market Cap | 47.35M | EPS (ttm) | - |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 56.40% | Inst Own | 0.18% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.52% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 50.54K | 52W Range | 2.50 - 7.60 |
|
|
|
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on July 10, 2014 and is headquartered in Doylestown, PA. |
|
|
|
Market Cap | 3.50M | EPS (ttm) | -0.61 |
P/E | - | EPS this Y | 21.88% |
Forward P/E | - | EPS next Y | 52.00% |
PEG | - | EPS past 5Y | - |
P/S | 2.52 | EPS next 5Y | - |
P/B | 0.68 | EPS Q/Q | 19.47% |
Dividend | - | Sales Q/Q | 164.61% |
Insider Own | 47.05% | Inst Own | 1.13% |
Insider Trans | 0.00% | Inst Trans | 70.03% |
Short Float | 0.55% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 0.60 |
Avg Volume | 203.74K | 52W Range | 0.17 - 2.77 |
|
|
|
Innovative Eyewear, Inc. retails eye glasses online. It designs and provides smart glasses enhanced with tech features such as built-in Bluetooth audio connectivity, phone control buttons and instant AI voice assistant access. The company was founded by Harrison Gross, Konrad Dabrowski and David Eric Cohen in 2019 and is headquartered in Miami, FL. |
|
| |
|
Market Cap | 165.17M | EPS (ttm) | -2.76 |
P/E | - | EPS this Y | 69.36% |
Forward P/E | - | EPS next Y | 57.62% |
PEG | - | EPS past 5Y | - |
P/S | 0.17 | EPS next 5Y | - |
P/B | 1.87 | EPS Q/Q | -282.51% |
Dividend | - | Sales Q/Q | -53.19% |
Insider Own | 17.57% | Inst Own | 34.63% |
Insider Trans | 0.00% | Inst Trans | -24.92% |
Short Float | 4.05% | Earnings | May 06/a |
Analyst Recom | 3.00 | Target Price | 7.30 |
Avg Volume | 27.05K | 52W Range | 6.20 - 15.19 |
|
|
|
Offerpad Solutions, Inc. engages in the operation of a real estate platform that enables consumers to seamlessly buy and sell properties using a mobile device. The company was founded by Brian Bair in July 2015 and is headquartered in Chandler, AZ. |
|
|
|
Market Cap | 12.60M | EPS (ttm) | -0.51 |
P/E | - | EPS this Y | 40.82% |
Forward P/E | - | EPS next Y | 41.38% |
PEG | - | EPS past 5Y | - |
P/S | 0.86 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -4.61% |
Dividend | - | Sales Q/Q | -73.54% |
Insider Own | 21.91% | Inst Own | 6.49% |
Insider Trans | 0.00% | Inst Trans | -7.07% |
Short Float | 0.65% | Earnings | Nov 15/b |
Analyst Recom | 1.00 | Target Price | 1.00 |
Avg Volume | 168.31K | 52W Range | 0.28 - 1.28 |
|
|
|
Splash Beverage Group, Inc. engages in the sale and production of natural and healthy drinks. It offers products under the brands of TapouT, Salt Tequila, Copa Di Vino, and Pulpoloco Sangria. The company was founded on September 3, 1992 and is headquartered in Fort Lauderdale, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nistico Robert | CEO and Chairman | Jun 16 '23 | Buy | 1.01 | 7,000 | 7,070 | 1,386,000 | Jun 16 11:19 AM |
|
|
| |
|
Market Cap | 11.53M | EPS (ttm) | -0.19 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 17.46 | EPS next 5Y | - |
P/B | 2.69 | EPS Q/Q | -89.96% |
Dividend | - | Sales Q/Q | 106.74% |
Insider Own | 81.21% | Inst Own | 0.17% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 2.10% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 368.52K | 52W Range | 0.55 - 19.21 |
|
|
|
Inno Holdings, Inc. engages in the marketing and sale of construction products. It offers services required to transform raw materials into precise steel framing products and prefabricated homes. The company was founded on September 8, 2021 and is headquartered in Brookshire, TX. |
|
|
|
Market Cap | 143.23M | EPS (ttm) | -1.47 |
P/E | - | EPS this Y | 28.71% |
Forward P/E | - | EPS next Y | 37.75% |
PEG | - | EPS past 5Y | -37.60% |
P/S | 1.53 | EPS next 5Y | - |
P/B | 4.37 | EPS Q/Q | 2.69% |
Dividend | - | Sales Q/Q | -14.29% |
Insider Own | 55.36% | Inst Own | 30.30% |
Insider Trans | -0.14% | Inst Trans | 3.88% |
Short Float | 4.70% | Earnings | May 13/a |
Analyst Recom | 1.38 | Target Price | 6.71 |
Avg Volume | 202.72K | 52W Range | 2.75 - 8.80 |
|
|
|
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McKelligon Brian | President and CEO | Mar 20 '24 | Option Exercise | 0.30 | 7,500 | 2,272 | 239,368 | Mar 22 05:54 PM | McKelligon Brian | President and CEO | Mar 20 '24 | Sale | 4.97 | 7,500 | 37,243 | 231,868 | Mar 22 05:54 PM | McKelligon Brian | President and CEO | Mar 13 '24 | Sale | 4.94 | 7,500 | 37,035 | 224,368 | Mar 14 08:41 PM | McKelligon Brian | President and CEO | Dec 19 '23 | Option Exercise | 0.30 | 7,500 | 2,272 | 160,063 | Dec 20 07:16 PM | McKelligon Brian | President and CEO | Dec 19 '23 | Sale | 4.48 | 7,500 | 33,566 | 152,563 | Dec 20 07:16 PM |
|
|
| |
|
Market Cap | 8.21M | EPS (ttm) | 0.15 |
P/E | 3.68 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | 807.17% |
Dividend | - | Sales Q/Q | - |
Insider Own | 23.05% | Inst Own | 10.01% |
Insider Trans | 0.00% | Inst Trans | 9.07% |
Short Float | 0.40% | Earnings | - |
Analyst Recom | 3.00 | Target Price | 1.80 |
Avg Volume | 1.07M | 52W Range | 0.52 - 15.40 |
|
|
|
Spectaire Holdings, Inc. is an industrial technology company that allows its customers to measure, manage, and reduce carbon dioxide equivalent (CO2e) and other greenhouse gas emissions. It offers AireCore, is a fully integrated hardware, software, and data platform. The company was founded in 2022 and is headquartered in Watertown, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Semkiw Brian | Chairman & CEO | Oct 25 '23 | Buy | 2.23 | 297 | 661 | 1,715,528 | Oct 26 07:25 PM | Mosolf Joerg | Director | Oct 24 '23 | Buy | 3.00 | 10,000 | 30,000 | 10,000 | Oct 26 07:26 PM | Semkiw Brian | Chairman & CEO | Oct 24 '23 | Buy | 1.94 | 1,899 | 3,685 | 1,715,231 | Oct 26 07:25 PM | Owl Creek Asset Management, L. | 10% Owner | Aug 17 '23 | Sale | 11.05 | 160,000 | 1,768,000 | 79,323 | Aug 21 06:21 PM |
|
|
|
|
Market Cap | 204.30M | EPS (ttm) | -6.83 |
P/E | - | EPS this Y | 118.52% |
Forward P/E | - | EPS next Y | -113.98% |
PEG | - | EPS past 5Y | - |
P/S | 0.59 | EPS next 5Y | 15.00% |
P/B | 0.44 | EPS Q/Q | -927.02% |
Dividend | - | Sales Q/Q | -0.83% |
Insider Own | 13.89% | Inst Own | 98.95% |
Insider Trans | -1.73% | Inst Trans | -4.16% |
Short Float | 18.10% | Earnings | May 09/b |
Analyst Recom | 2.78 | Target Price | 8.21 |
Avg Volume | 740.89K | 52W Range | 4.75 - 36.79 |
|
|
|
Cerence, Inc. engages in building artificial intelligence-powered virtual assistants for the mobility and transportation market. Its products include core technologies, cloud and professional services, voice and beyond, mobility, and platform developers. The company was founded on October 1, 2019 and is headquartered in Burlington, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BEAUDOIN THOMAS L | Director | May 07 '24 | Sale | 9.69 | 5,464 | 52,946 | 242,457 | May 08 04:22 PM | BEAUDOIN THOMAS L | Director | May 01 '24 | Sale | 9.03 | 5,000 | 45,146 | 247,921 | May 02 05:08 PM | Ortmanns Stefan | Chief Executive Officer | Apr 22 '24 | Sale | 10.04 | 10,762 | 108,045 | 526,388 | Apr 23 04:44 PM | BEAUDOIN THOMAS L | Director | Apr 01 '24 | Sale | 15.35 | 5,000 | 76,744 | 252,921 | Apr 02 09:28 AM | Ortmanns Stefan | Chief Executive Officer | Mar 22 '24 | Sale | 14.82 | 15,389 | 228,043 | 537,150 | Mar 25 05:15 PM |
|
|
|
|
Market Cap | 39.26M | EPS (ttm) | -1.00 |
P/E | - | EPS this Y | 22.95% |
Forward P/E | - | EPS next Y | 40.71% |
PEG | - | EPS past 5Y | 0.80% |
P/S | 1.31 | EPS next 5Y | - |
P/B | 0.94 | EPS Q/Q | -11.97% |
Dividend | - | Sales Q/Q | 2.09% |
Insider Own | 5.49% | Inst Own | 39.59% |
Insider Trans | 38.09% | Inst Trans | -2.20% |
Short Float | 10.69% | Earnings | May 13/b |
Analyst Recom | 1.80 | Target Price | 1.35 |
Avg Volume | 661.50K | 52W Range | 0.40 - 3.57 |
|
|
|
Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. It operates through the Foundry Fabrication Services and RF Filters segments. The Foundry Fabrication Services segment is composed of engineering review services and STC-MEMS foundry services. The RF Filters segment includes amplifier and filter product sales, and grant revenue. The company was founded by Jeffrey B. Shealy in 2014 and is headquartered in Huntersville, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shealy Jeffrey B. | Chief Executive Officer | Jan 29 '24 | Buy | 0.50 | 1,310,000 | 655,000 | 2,222,775 | Jan 31 06:39 PM | Aichele David | EVP of Business Development | Jan 29 '24 | Buy | 0.50 | 80,000 | 40,000 | 334,622 | Jan 31 06:39 PM | Boller Kenneth | CFO | Jan 29 '24 | Buy | 0.50 | 60,000 | 30,000 | 214,957 | Jan 31 06:39 PM | Geiss Arthur | Director | Jan 29 '24 | Buy | 0.50 | 50,000 | 25,000 | 415,924 | Jan 31 06:40 PM | Aichele David | EVP of Business Development | Dec 18 '23 | Sale | 0.72 | 1,500 | 1,083 | 254,622 | Dec 20 05:03 PM |
|
|
|